Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18,440 JPY | -3.05% | +10.42% | +114.67% |
2023 | ISE Chemicals Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2018 | ISE Chemicals Corporation announces an Equity Buyback for 56 shares, for ¥0.18 million. | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The group's high margin levels account for strong profits.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The firm trades with high earnings multiples: 20.43 times its 2024 earnings per share.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+114.67% | 615M | - | ||
-1.20% | 66.01B | A- | ||
+47.62% | 41.76B | B | ||
+15.99% | 38.66B | B | ||
+4.25% | 32.28B | A- | ||
+8.78% | 19.57B | B- | ||
+12.32% | 16.77B | C+ | ||
+17.69% | 15.08B | B- | ||
+8.31% | 14.83B | B | ||
-14.59% | 13.95B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4107 Stock
- Ratings ISE Chemicals Corporation